ACHC renews accreditation for Axium Healthcare Pharmacy
LAKE MARY, Fla. — A group that accredits healthcare organizations has renewed its certification for the Kroger Co.’s specialty pharmacy division.
Axium Healthcare Pharmacy said Wednesday that it received a renewal of its accreditation status from the Accreditation Commission for Health Care for its specialty pharmacy services.
"The renewal of our ACHC accreditation status is a testament to our commitment to our patients, as well as our healthcare partners," Axium president and CEO Mark Montgomery said. "In receiving this continued validation from ACHC, we have demonstrated that our focus on the highest standards in specialty pharmacy has not gone unnoticed."
Review by the ACHC includes onsite surveys by industry experts and assessments of a healthcare company’s organizational structure, policies, procedures, fiscal activities, human resources, quality outcomes, infection control, patient and employee safety and more.
Giant Eagle to begin providing prescription delivery service in Columbus, Ohio, market
COLUMBUS, Ohio — Giant Eagle is launching a prescription delivery service beginning next week, according to a report published Wednesday in the Columbus Dispatch.
The initiative is expected to drive prescription growth. "More and more customers [who] think of Giant Eagle as their grocery store, [will] think of Giant Eagle pharmacy as their drug store," Brett Merrell, SVP health and wellness, told the Dispatch.
Starting Monday, Giant Eagle will deliver prescriptions free within a 10-mile radius of each of its 22 central Ohio groceries with in-store pharmacies.
Kroger provides a similar service in the market, the Dispatch noted.
NACDS, NCPA urge CMS to ensure fair, accurate reimbursement for Medicaid drugs
ARLINGTON, Va. — With the expansion of Medicaid services in the Patient Protection and Affordable Care Act on the horizon, the National Association of Chain Drug Stores and National Community Pharmacists Association sent a letter to CMS urging the agency to take into consideration the true cost of dispensing prescription medications to Medicaid patients.
In a letter to CMS, NACDS and NCPA stressed that to maintain patient access to pharmacies, CMS must ensure that states increase dispensing fees for Medicaid drugs in conjunction with the upcoming new Federal Upper Limits anticipated in 2014.
CMS is currently in the process of determining new Medicaid FULs that would apply to pharmacy reimbursement for many common generic medications. NACDS and NCPA have repeatedly expressed concern about the reimbursement limits proposed to date by CMS because the associations believe that they would fail to cover even the pharmacy’s acquisition costs for hundreds of products.
In the letter, NACDS and NCPA emphasized that the average manufacturer price is an inaccurate benchmark for pharmacy reimbursement, and that there is no correlation between the weighted AMP and pharmacy acquisition costs.
“In a number of instances, the AMP-based FUL is lower than the pharmacy’s acquisition cost for a given drug,” the groups stated in the letter. “In light of the looming problem of under-reimbursement, it is important for CMS to advocate to State Medicaid directors the importance of increasing dispensing fees to account for this problem. We urge CMS to make clear to states that in order to maintain patient access to pharmacies, dispensing fees must be increased to reflect no less than the true cost of dispensing prescription medications to Medicaid patients.”
NACDS and NCPA also cite that if states do not increase their dispensing fees, Medicaid patient access to pharmacy may be at risk.
“If states fail to increase Medicaid dispensing fees at the same time that AMP-based reimbursement is falling, then pharmacies may be forced to withdraw from the Medicaid program, denying patients access to Medicaid drugs,” the groups stated in the letter.